Sort
17,828 grants matching “crispr”
MSCS ENGINEERED TO PRODUCE BDNF AND GENE EDITING CARGO FOR THE TREATMENT OF HUNTINGTON'S DISEASE
$346,046Kyle Fink · University Of California At Davis · R01 · FY2025 · NS
Hematology Training Program
$345,998Margaret Goodell · Baylor College Of Medicine · T32 · FY2022 · DK
Use of the PBS1 Decoy System to Engineer Resistance to Plant-Parasitic Nematodes
$345,990Roger W Innes · Indiana University · · FY2020 · BIO
Project 4: Novel epigenetic treatment of IDH mutant gliomas
$345,939Harley I Kornblum · University Of California Los Angeles · P50 · FY2019 · CA
Transgenic Core
$345,800Bradford B Lowell · Food Allergy Science Initiative, Inc. · P01 · FY2024 · AI
Transgenic Core
$345,800Bradford B Lowell · Food Allergy Science Initiative, Inc. · P01 · FY2025 · AI
Functional Genomic Screening to Identify Therapeutic Targets in Human Diseases
$345,701Ken Cheng · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance
$345,678Michael C Bassik · Stanford University · U54 · FY2023 · CA
Project 1: Aberrant neuronal activity and tau distribution in FTD
$345,495Li Gan · Weill Medical Coll Of Cornell Univ · U54 · FY2020 · NS
Project 1: Aberrant neuronal activity and tau distribution in FTD
$345,493Li Gan · Weill Medical Coll Of Cornell Univ · U54 · FY2019 · NS
Proteasome inhibitors for the treatment of solid tumors
$345,478Alexei Kisselev · Auburn University At Auburn · R01 · FY2019 · CA
Rapid, in vitro phenotyping of monogenic neurological disorders using CRISPRi and high-throughput all-optical electrophysiology.
$345,471Christopher Werley · Q-State Biosciences, Inc. · R43 · FY2017 · MH
Modular protein switches
$345,368Marc A Ostermeier · Johns Hopkins University · · FY2018 · ENG
Targeting the epithelial to mesenchymal transition-mediated chemoresistance in breast cancer
$345,356Dingcheng Gao · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · CA
Targeting the epithelial to mesenchymal transition-mediated chemoresistance in breast cancer
$345,356Dingcheng Gao · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · CA
Targeting the epithelial to mesenchymal transition-mediated chemoresistance in breast cancer
$345,356Dingcheng Gao · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · CA
Targeting the epithelial to mesenchymal transition-mediated chemoresistance in breast cancer
$345,356Dingcheng Gao · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Complex Mechanisms of Mutation and Mutation Avoidance in Living Cells
$345,348Eric Alan Josephs · University Of North Carolina Greensboro · R35 · FY2022 · GM
Epigenetic disruptions of PBDEs during neurodevelopment
$345,261Ramendra N Saha · University Of California, Merced · R01 · FY2019 · ES
Targeting PTPN11 dependent Hematologic Malignancies
$345,230Bill H Chang · Oregon Health & Science University · R01 · FY2023 · CA
Targeting PTPN11 dependent Hematologic Malignancies
$345,230Bill H Chang · Oregon Health & Science University · R01 · FY2022 · CA
Mechanisms of venetoclax combination activity in acute myeloid leukemia
$345,230Jeffrey Wallace Tyner · Oregon Health & Science University · R01 · FY2023 · CA
Mechanisms of venetoclax combination activity in acute myeloid leukemia
$345,230Jeffrey Wallace Tyner · Oregon Health & Science University · R01 · FY2022 · CA
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
$345,184James A Wells · University Of California, San Francisco · R01 · FY2024 · CA
Germline transmission of epigenetic alterations to offspring
$345,153Ramji Kumar Bhandari · University Of Missouri-Columbia · R01 · FY2024 · ES